Status:
COMPLETED
Rocuronium vs Cis-atracurium: Do Rocuronium Still 'ROCKS' In Coronary Artery Bypass Grafting
Lead Sponsor:
Institut Jantung Negara
Conditions:
Neuromuscular Blockade
Postoperative Pulmonary Atelectasis
Eligibility:
All Genders
18+ years
Brief Summary
The current trend in most cardiac surgeries was to use rocuronium as it provides faster recovery in train-of-four ratio compared to other aminosteroid non-depolarising neuromuscular blocker. However, ...
Eligibility Criteria
Inclusion
- All patients that undergo general anaesthesia for CABG surgery requiring neuromuscular blockade of either rocuronium or cis-atracurium
Exclusion
- Recent history of pulmonary infection four weeks before surgery
- Exposed to both neuromuscular blockade within 24 hours perioperatively
- Patients intubated or on tracheostomies pre-operatively
- Any missing or incomplete data
Key Trial Info
Start Date :
August 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 23 2023
Estimated Enrollment :
289 Patients enrolled
Trial Details
Trial ID
NCT06102915
Start Date
August 1 2023
End Date
November 23 2023
Last Update
November 28 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institut Jantung Negara
Kuala Lumpur, Malaysia, 50400